Project Grant R15CA271365

Award Date 3/1/22
Completion Date 2/28/26
Dollars Obligated $419K
Federal Grant Program
93.394
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This Project Grant award from the National Science Foundation (CFDA 47.049 - Mathematical and Physical Sciences) provides $615,000 in funding to the University of Texas at San Antonio (UTSA), in collaboration with Bristol Myers Squibb, to develop new metal-based catalysts that precisely control carbon-oxygen or carbon-nitrogen bond formation in pharmaceutically relevant molecules. The goal is to improve the efficiency and sustainability of manufacturing routes for pharmaceutical drugs on an...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $357,056 from January 1, 2025 to December 31, 2029 to Wayne State University to develop innovative tools for modern organic synthesis and pharmaceutical development. The key objectives are: 1) Developing colloidal suspensions of commonly insoluble inorganic reagents to allow their use in high-throughput experimentation workflows, 2)...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $283,805 in funding to Invizyne Technologies, Inc., a small disadvantaged business located in Monrovia, California. The project, titled "BIO-CLICK: A CELL-FREE HIGH-THROUGHPUT PLATFORM FOR THE ENGINEERING OF ENZYMATIC GROUP TRANSFER REACTIONS", aims to develop a novel cell-free, high-throughput platform to expedite...
This Project Grant award of $388,621 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development of novel molecular designs with therapeutic potential. The key objectives are: Developing ligand-heterocycle conjugates as targeted RNA degraders with rapid kinetics and selectivity for cancer-associated G-quadruplexes. Engineering nucleic acid polymers with (thio)phosphoramidate backbones as biostable...
This Project Grant award from the National Science Foundation's (NSF) Mathematical and Physical Sciences program (CFDA 47.049) provides $272,799 to South Dakota State University (SDSU) to conduct foundational research on polymer nanoparticles (polymersomes) that can simultaneously release encapsulated contents under specific biochemical conditions and respond to ultrasound for imaging and controlled release. The research team aims to optimize the design of these multimodal polymer...
This $337,863 Project Grant awarded by the National Science Foundation's (NSF) Division of Chemistry under the Mathematical and Physical Sciences program (CFDA 47.049) supports research by Professor Ken Marcus and his team at Clemson University to develop new methods for isolating and purifying diverse biological nanoparticles, including exosomes, lentiviruses, and adeno-associated viruses. The researchers aim to characterize and implement a unique fiber-based stationary phase,...
This $575,000 project grant awarded by the National Science Foundation's (NSF) Division of Chemistry under the Mathematical and Physical Sciences program (CFDA 47.049) supports research at Emory University to develop practical methods for conducting synthetic organic transformations using low catalyst loadings. The goal is to create highly efficient catalysts, such as rhodium and ruthenium-based catalysts, that can be used in extremely low amounts to enable over 100,000 reaction cycles while...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $280,160 to Palladias LLC to develop inexpensive and reusable sorbents that effectively remove palladium from the products of palladium-catalyzed cross-coupling reactions. This is a common type of reaction used extensively in pharmaceutical discovery, but its widespread use in pharmaceutical process chemistry to synthesize medicines...
The National Science Foundation (NSF) Division of Molecular and Cellular Biosciences awarded a $590,000 Project Grant to the University of California Irvine (UC Irvine) on August 15, 2023 under the Biological Sciences program (CFDA 47.074). The goal of this 3-year research project is to develop novel strategies for real-time metabolite sensing and metabolite-induced enzyme localization that can contribute to fundamental cellular knowledge and improve the efficiency of synthetic biology...
This $400,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will fund research to develop an integrated computational framework for predicting and designing "photoenzymes" - enzymes that can utilize light to catalyze non-natural chemical reactions important for pharmaceutical synthesis. The key products or services to be delivered include: 1) Machine learning-enhanced...

PHARMACEUTICAL NANOFACTORIES: INTRACELLULAR SYNTHESIS OF BIOACTIVE DRUG MOLECULES - PROJECT SUMMARY: SINCE THE DISCOVERY OF ANTICANCER AND CHEMOTHERAPEUTIC PHARMACEUTICALS, SOCIETY HAS BEEN CHALLENGED BY DETRIMENTAL AND LIFE ALTERING SIDE EFFECTS, DRUG RESISTANCE VIA CELLULAR MUTATIONS, AND DISTRIBUTED NON- METABOLIZED PHARMACEUTICALS BACK INTO THE ENVIRONMENT, WHICH HAS LONG-TERM EFFECTS ON WILDLIFE AND WATER SUPPLIES. THE SYNTHETIC CONTROL MY TEAM HAS ON THE PORE ENVIRONMENT OF MESOPOROUS SILICA NANOPARTICLES (MSN) OFFERS A UNIQUE PERSPECTIVE OF DELIVERING ACTIVE, HETEROGENOUS CATALYTIC SPECIES TO CELLS. USING THE VAST KNOWLEDGE BASE ALREADY KNOWN ON INTERNALIZING MSN VIA ENDOCYTOSIS FOR DRUG DELIVERY, WE WILL DESIGN BIOCOMPATIBLE POROUS NANOMATERIALS THAT WILL ENTER CELLS WITH INORGANIC AND BIOLOGICAL CATALYSTS ENTRAPPED INSIDE THE PORES. PROTECTED MOLECULES THAT ARE NOT BIOLOGICALLY ACTIVE WILL BECOME ACTIVATED ONCE THEY ENCOUNTER THE CATALYTIC ACTIVE SITES. THE CONFINED SPACE OFFERED BY THE MESOPORES WILL PROTECT THE CATALYTIC SPECIES (TETHERED MOLECULAR CATALYSTS AND EXOGENOUS ENZYMES) FROM THE REDUCTIVE ENVIRONMENT OF THE CELLS. WE CAN SELECTIVELY FUNCTIONALIZE THE EXTERNAL AND INTERNAL PORE ENVIRONMENTS, ALLOWING US TO CONTROL THE INTERNALIZATION AND STABILIZATION INTRACELLULARLY ALONG WITH CATALYTIC PROPERTIES. CURRENT TECHNOLOGY TO DELIVER BIOLOGICALLY ACTIVE MOLECULES CONTAINS NUMEROUS DISADVANTAGES THE SITE-SPECIFIC SYNTHESIS COULD ELIMINATE. THE SCIENTIFIC INNOVATION INCLUDES A SYSTEMATIC INVESTIGATION OF NOVEL POROUS, BIOMATERIALS ENTRAPPING METAL CATALYSTS AND ENZYMES TO INVESTIGATE THE SYNTHESIS AND ACTIVATION OF PRODRUG AND PROFLUOROPHORE MOLECULES INTRACELLULARLY. THE HYPOTHESIS IS THAT IF CATALYSTS CAN BE SUPPORTED AND PROTECTED IN THE PORE STRUCTURE OF MSN AND THE NANOMATERIAL WILL BE INTERNALIZED BY CELLS, THEN BIOORTHOGONAL CHEMICAL REACTIONS CAN BE CONDUCTED INTRACELLULARLY TO PRODUCE BIOLOGICALLY ACTIVE MOLECULES ON SITE ELIMINATING THE NEED FOR DELIVERY OF DRUG MOLECULES THAT HAVE DETRIMENTAL SIDE EFFECTS AND LEAD TO RESISTANCE. THE TEACHING INNOVATION OF THIS PROJECT IS IN THE COOPERATIVE AND TEAM-ORIENTED RESEARCH ACTIVITIES INVOLVING PARTICIPANTS FROM HIGH SCHOOL THROUGH THE PI. STUDENTS WILL RECEIVE HANDS-ON TRAINING ON NUMEROUS STATE-OF-THE-ART INSTRUMENTATIONS ALONG WITH CHEMICAL SYNTHESES, CHARACTERIZATION, AND BIOCHEMICAL TECHNIQUES. THIS RESEARCH WILL ALSO BE USED TO GUIDE WEEKLY UNDERGRADUATE BIOCHEMISTRY LABORATORY EXPERIMENTS, FOCUSED ON IMPORTANT INTERACTIONS BETWEEN BIOMOLECULES AND INORGANIC SUBSTRATES FOR ENZYME STABILIZATION AND AS PART OF THE CURRICULUM IN LECTURE COURSES. THE IMPACT TO STUDENTS IS FIRST-HAND EXPERIENCE IN WORKING COOPERATIVELY AND ESSENTIAL SKILLS THAT GO INTO SCIENTIFIC RESEARCH AND UNDERSTANDING, SUCH AS THE IMPORTANCE OF PROPER CONTROLS, STATISTICAL ANALYSIS, AND COMMUNICATION SKILLS THAT ARE REQUIRED IN SCIENCE AND ENGINEERING.

Posted 2/28/22, 12:00 AM